Skip to main content

Table 2 Cox proportional hazards regression analyses on the relationship between hypoxia and ClockLoss or ClockGain on overall survival

From: Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies

 

Hazard ratio (95% CI)

P-value

Glioma (ClockLoss)

 Low ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

7.218 (4.234–12.304)

< 0.0001

 High ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

3.138 (1.733–5.683)

0.00016

 High ClockLoss and low hypoxia score vs. low ClockLoss and low hypoxia score

1.114 (0.617–2.014)

0.72

Pan-kidney (ClockLoss)

 Low ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

2.512 (1.732–3.643)

< 0.0001

 High ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

1.580 (1.094–2.282)

0.0148

 High ClockLoss and low hypoxia score vs. low ClockLoss and low hypoxia score

0.695 (0.423–1.122)

0.14

Clear cell renal cell (ClockLoss)

 Low ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

1.893 (1.207–2.969)

0.0054

 High ClockLoss and high hypoxia score vs. low ClockLoss and low hypoxia score

1.285 (0.761–2.170)

0.35

 High ClockLoss and low hypoxia score vs. low ClockLoss and low hypoxia score

0.796 (0.479–1.324)

0.38

Glioma (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

9.210 (6.182–13.721)

< 0.0001

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.550 (0.917–2.622)

0.11

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

3.317 (2.105–5.228)

< 0.0001

Astrocytoma (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

5.684 (2.770–11.662)

< 0.0001

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.451 (0.527–3.998)

0.47

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

2.378 (0.985–5.736)

0.054

Oligodendroglioma (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

4.085 (1.656–10.068)

0.0022

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.218 (0.439–3.374)

0.71

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

1.541 (0.581–4.091)

0.38

Pan-kidney (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

3.079 (2.040–4.646)

< 0.0001

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.742 (1.089–2.785)

0.021

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

2.823 (1.850–4.307)

< 0.0001

Clear cell renal cell (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

1.877 (1.222–2.884)

0.0041

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.189 (0.742–1.908)

0.47

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

1.630 (1.043–2.546)

0.032

Lung (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

2.037 (1.327–3.129)

0.0012

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

1.332 (0.755–2.351)

0.33

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

1.995 (1.221–3.258)

0.0058

Pancreas (ClockGain)

 High ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

1.976 (1.163–3.357)

0.012

 High ClockGain and low hypoxia score vs. low ClockGain and low hypoxia score

0.852 (0.344–2.110)

0.73

 Low ClockGain and high hypoxia score vs. low ClockGain and low hypoxia score

0.893 (0.397–2.009)

0.79

  1. Significant P values are marked in italics
  2. CI confidence interval